Prion protein genes and prion diseases: studies in transgenic mice

被引:24
|
作者
Telling, GC
机构
[1] Univ Kentucky, Dept Microbiol & Immunol, Sanders Brown Ctr Aging, Lexington, KY 40536 USA
[2] Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA
关键词
prions; transgenic mice;
D O I
10.1046/j.1365-2990.2000.00253.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In the past decade, manipulation of PrP genes by transgenesis in mice has provided important insights into mechanisms of prion propagation and the molecular basis of prion strains and species barriers. Despite these advances, our understanding of these unique pathogens is far from complete. This review focuses on PrP gene knockout and gene replacement studies, PrP structure and function, and transgenic models of human and animal prion diseases. Transgenic approaches will doubtless remain the cornerstone of investigations into the prion diseases in the coming years, which will include mechanistic studies of prion pathogenesis and prion transmission barriers. Transgenic models will also be important tools for the evaluation of potential therapeutic agents for prion diseases.
引用
收藏
页码:209 / 220
页数:12
相关论文
共 50 条
  • [21] PRION PROTEIN TRANSGENES AND THE NEUROPATHOLOGY IN PRION-DISEASES
    DEARMOND, S
    PRUSINER, SB
    BRAIN PATHOLOGY, 1995, 5 (01) : 77 - 89
  • [22] Evidence for oxidative damage to prion protein in prion diseases
    YANG Chiming (Chi Ming Yang)Institute for Life Science and Health at UCSD
    Chinese Science Bulletin, 2000, (17) : 1546 - 1554
  • [23] Short term synaptic plasticity in prion protein transgenic mice
    Korte, S
    Herms, JW
    Kretzschmar, HA
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 : 16 - 16
  • [24] Protein misfolding and prion diseases
    Cohen, FE
    JOURNAL OF MOLECULAR BIOLOGY, 1999, 293 (02) : 313 - 320
  • [25] Molecular studies of prion diseases
    Safer, J
    Prusiner, SB
    NEURONAL DEGENERATION AND REGENERATION: FROM BASIC MECHANISMS TO PROSPECTS FOR THERAPY, 1998, 117 : 421 - 434
  • [26] Prion protein interaction with nucleic acids: Possible models for prion diseases and prion function
    Grossman, A
    Zeiler, B
    Adler, V
    Kryukov, V
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S71 - S71
  • [27] Presumptive BSE cases with an aberrant prion protein phenotype in Switzerland, 2011: Lack of prion disease in experimentally inoculated cattle and bovine prion protein transgenic mice
    Serra, F.
    Dudas, S.
    Torres, J. M.
    Anderson, R.
    Oevermann, A.
    Espinosa, J. C.
    Czub, S.
    Seuberlich, T.
    TRANSBOUNDARY AND EMERGING DISEASES, 2018, 65 (05) : 1348 - 1356
  • [28] Prion protein NMR structure and species barrier for prion diseases
    Billeter, M
    Riek, R
    Wider, G
    Hornemann, S
    Glockshuber, R
    Wuthrich, K
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (14) : 7281 - 7285
  • [29] Prion diseases and emerging prion diseases
    Yokoyama, Takashi
    Mohri, Shirou
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (09) : 912 - 916
  • [30] Cerebrospinal Fluid Total Prion Protein in the Spectrum of Prion Diseases
    Villar-Pique, Anna
    Schmitz, Matthias
    Lachmann, Ingolf
    Karch, Andre
    Calero, Olga
    Stehmann, Christiane
    Sarros, Shannon
    Ladogana, Anna
    Poleggi, Anna
    Santana, Isabel
    Ferrer, Isidre
    Mitrova, Eva
    Zakova, Dana
    Pocchiari, Maurizio
    Baldeiras, Ines
    Calero, Miguel
    Collins, Steven J.
    Geschwind, Michael D.
    Sanchez-Valle, Raquel
    Zerr, Inga
    Llorens, Franc
    MOLECULAR NEUROBIOLOGY, 2019, 56 (04) : 2811 - 2821